Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

B7-H3: A costimulatory molecule for T cell activation and IFN-γ production

Abstract

We describe here a newly identified member of the human B7 family, designated B7 homolog 3 (B7-H3), that shares 20–27% amino acid identity with other B7 family members. B7-H3 mRNA is not detectable in peripheral blood mononuclear cells, although it is found in various normal tissues and in several tumor cell lines. Expression of B7-H3 protein, however, can be induced on dendritic cells (DCs) and monocytes by inflammatory cytokines and a combination of phorbol myristate acetate (PMA) + ionomycin. Soluble B7-H3 protein binds a putative counter-receptor on activated T cells that is distinct from CD28, cytotoxic T lymphocyte antigen 4 (CTLA-4), inducible costimulator (ICOS) and PD-1. B7-H3 costimulates proliferation of both CD4+ and CD8+ T cells, enhances the induction of cytotoxic T cells and selectively stimulates interferon γ (IFN-γ) production in the presence of T cell receptor signaling. In contrast, inclusion of antisense B7-H3 oligonucleotides decreases the expression of B7-H3 on DCs and inhibits IFN-γ production by DC-stimulated allogeneic T cells. Thus, we describe a newly identified costimulatory pathway that may participate in the regulation of cell-mediated immune responses.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Putative amino acid sequence of human B7-H3 and alignment of B7 family members.
Figure 2: Northern blot analysis of B7-H3 mRNA.
Figure 3: Analysis of B7-H3 expression by flow cytometry.
Figure 4: Binding of B7-H3–Ig to activated T cells.
Figure 5: B7-H3 costimulates T cell growth and enhances CTL generation.
Figure 6: B7-H3 augments the expression of IFN-γ.
Figure 7: Inhibition of B7-H3 expression on DCs and IFN-γ production from DC-activated allogeneic T cells by B7-H3 antisense oligonucleotides.

Similar content being viewed by others

References

  1. Linsley, P. S. & Ledbetter, J. A. The role of the CD28 receptor during T cell responses to antigen. Annu. Rev. Immunol. 11, 191–212 (1993).

    Article  CAS  Google Scholar 

  2. Lenschow, D. J., Walunas, T. L. & Bluestone, J. A. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14, 233–258 (1996).

    Article  CAS  Google Scholar 

  3. Chambers, C. A. & Allison, J. P. Co-stimulation in T cell responses. Curr. Opin. Immunol. 9, 396–404 (1997).

    Article  CAS  Google Scholar 

  4. Boise, L. H., Noel, P. J. & Thompson, C. B. CD28 and apoptosis. Curr. Opin. Immunol. 7, 620–625 (1995).

    Article  CAS  Google Scholar 

  5. Rathmell, J. C. & Thompson, C. B. The central effectors of cell death in the immune system. Annu. Rev. Immunol. 17, 781–828 (1999).

    Article  CAS  Google Scholar 

  6. Krummel, M. F. & Allison, J. P. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J. Exp. Med. 183, 2533–2540 (1996).

    Article  CAS  Google Scholar 

  7. Walunas, T. L., Bakker, C. Y. & Bluestone, J. A. CTLA-4 ligation blocks CD28-dependent T cell activation. J. Exp. Med. 183, 2541–2550 (1996).

    Article  CAS  Google Scholar 

  8. Dong, H., Zhu, G., Tamada, K. & Chen, L. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nature Med. 5, 1365–1369 (1999).

    Article  CAS  Google Scholar 

  9. Hutloff, A. et al. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature 397, 263–266 (1999).

    Article  CAS  Google Scholar 

  10. Ishida, Y., Agata, Y., Shibahara, K. & Honjo, T. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBO J. 11, 3887–3895 (1992).

    Article  CAS  Google Scholar 

  11. Freeman, G. J. et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 192, 1027–1034 (2000).

    Article  CAS  Google Scholar 

  12. Swallow, M. M., Wallin, J. J. & Sha, W. C. B7h, a novel costimulatory homolog of B7.1 and B7.2, is induced by TNFα. Immunity. 11, 423–432 (1999).

    Article  CAS  Google Scholar 

  13. Yoshinaga, S. K. et al. T-cell co-stimulation through B7RP-1 and ICOS. Nature 402, 827–832 (1999).

    Article  CAS  Google Scholar 

  14. Ling, V. et al. Identification of GL50, a novel B7-like protein that functionally binds to ICOS receptor. J. Immunol. 164, 1653–1657 (2000).

    Article  CAS  Google Scholar 

  15. Mages, H. W. et al. Molecular cloning and characterization of murine ICOS and identification of B7h as ICOS ligand. Eur. J. Immunol. 30, 1040–1047 (2000).

    Article  CAS  Google Scholar 

  16. Brodie, D. et al. LICOS, a primordial costimulatory ligand? Curr. Biol. 10, 333–336 (2000).

    Article  CAS  Google Scholar 

  17. Wang, S. et al. Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS. Blood 96, 2808–2813 (2000).

    CAS  PubMed  Google Scholar 

  18. Yoshinaga, S. K. et al. Characterization of a new human B7-related protein: B7RP-1 is the ligand to the co-stimulatory protein ICOS. Int. Immunol. 12, 1439–1447 (2000).

    Article  CAS  Google Scholar 

  19. Aicher, A. et al. Characterization of human inducible costimulator ligand expression and function. J. Immunol. 164, 4689–4696 (2000).

    Article  CAS  Google Scholar 

  20. Linsley, P. S., Peach, R., Gladstone, P. & Bajorath, J. Extending the B7 (CD80) gene family. Protein Sci. 3, 1341–1343 (1994).

    Article  CAS  Google Scholar 

  21. Henry, J., Miller, M. M. & Pontarotti, P. Structure and evolution of the extended B7 family. Immunol. Today 20, 285–288 (1999).

    Article  CAS  Google Scholar 

  22. Chapoval, A. I., Zhu, G. & Chen, L. Immunoglodulin fusion protein as a tool for evaluation of T-cell costimulatory molecules. Methods Mol. Med. 45, 247–255 (2000).

    CAS  PubMed  Google Scholar 

  23. Linsley, P. S. et al. Coexpression and functional cooperation of CTLA-4 and CD28 on activated T lymphocytes. J. Exp. Med. 176, 1595–1604 (1992).

    Article  CAS  Google Scholar 

  24. Pechhold, K. et al. Inflammatory cytokines IFN-γ plus TNF-α induce regulated expression of CD80 (B7-1) but not CD86 (B7-2) on murine fibroblasts. J. Immunol. 158, 4921–4929 (1997).

    CAS  PubMed  Google Scholar 

  25. Lenschow, D. J. et al. Differential up-regulation of the B7-1 and B7-2 costimulatory molecules after Ig receptor engagement by antigen. J. Immunol. 153, 1990–1997 (1994).

    CAS  PubMed  Google Scholar 

  26. Kayagaki, N. et al. Metalloproteinase-mediated release of human Fas ligand. J. Exp. Med. 182, 1777–1783 (1995).

    Article  CAS  Google Scholar 

  27. Lindsten, T. et al. Characterization of CTLA-4 structure and expression on human T cells. J. Immunol. 151, 3489–3499 (1993).

    CAS  PubMed  Google Scholar 

  28. Farrar, M. A. & Schreiber, R. D. The molecular cell biology of interferon-γ and its receptor. Annu. Rev. Immunol. 11, 571–611 (1993).

    Article  CAS  Google Scholar 

  29. Chapoval, A. I., Tamada, K. & Chen, L. In vitro growth inhibition of a broad spectrum of tumor cell lines by activated human dendritic cells. Blood 95, 2346–2351 (2000).

    CAS  PubMed  Google Scholar 

  30. Tamada, K. et al. LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response. J. Immunol. 164, 4105–4110 (2000).

    Article  CAS  Google Scholar 

  31. Chapoval, A. I., Fuller, J. A., Kremlev, S. G., Kamdar, S. J. & Evans, R. Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells. J. Immunol. 161, 6977–6984 (1998).

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

Supported by the Mayo Foundation and grants from the National Institutes of Health (NIH) (to L. C.), NIH postdoctoral training grant CA09127 (to A. I. C. and G. Z.), the US Army Breast Cancer Research Program postdoctoral fellowship (to K. T.) and NIH predoctoral training grant AI07425 (to J. S. L.). We thank K. Jensen for editing the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lieping Chen.

Supplementary information

Web Figure 1.

Expression of B7-H3 on DCs. Monocyte-derived DCs were generated as described in the Methods, treated with either IFN-γ (left column) or PMA + ionomycin (right column) at indicated concentration for 24 h and subsequently stained with anti-B7-H3. (GIF 33 kb)

Web Figure 2.

Expression of B7-H3 on CD14+ cells. CD14+ monocytes were isolated from peripheral blood mononuclear cells of healthy donors and stimulated with either GM-CSF (left column) or PMA + ionomycin (right column) at indicated concentration for 24 h and subsequently stained with anti-B7-H3. (GIF 27 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chapoval, A., Ni, J., Lau, J. et al. B7-H3: A costimulatory molecule for T cell activation and IFN-γ production. Nat Immunol 2, 269–274 (2001). https://doi.org/10.1038/85339

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/85339

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing